LGND - Ligand Pharmaceuticals Incorporated Company Cash Volume

Public company logo of ligand.com (LGND)

Ligand Pharmaceuticals (LGND) minimizes capital expenditures by outsourcing production and testing to third-party contractors. Current cash levels illustrate the financial resilience of this strategy, where 0.45 determines this specific parameter level. The company's revenues are based on royalties from the Captisol platform, while capital stability is ensured by OmniAb technologies, which eliminate operational risks during the development of new drugs.

Ligand Pharma - LGND Company Cash Balance (period 07/04/2022 - 11/21/2026)

Financial and market metric breakdowns for Ligand (LGND)

- stock value and consensus price forecast:
Comprehensive company analysis:LGND Ligand Pharmaceuticals
Brand item of ligand.com

For the biopharmaceutical business of Ligand Pharmaceuticals (LGND), with its focus on high-tech R&D and AI screening, liquidity is critical to ensuring the continuity of innovation. By analyzing the organization's cash balances, an investor assesses the balance between financial autonomy during inflationary periods and capital efficiency, where excess cash may indicate underinvestment in growth, thereby defining the risk profile of this security.

Direct competitors

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|AMRX: Company Cash on Hand|Company Cash Reserve Perrigo Company plc|ALVO: Company Cash Volume|Liquidia (LQDA) - Company Cash Volume|Company Cash Funds Galapagos N.V.|Company Cash on Hand ANI Pharmaceuticals, Inc. (ANIP)|Company Cash Volume MNKD|AMPH (Amphastar Corp) - Company Cash Balance|Company Cash Funds pacira.com PCRX|SPRY - Company Cash on Hand|Theravance Biopharma, Inc. - Company Cash Volume|Company Cash Balance AQST (Aquestive Therapeutics, Inc.)|SCPH: Company Cash Volume|Tectonic Therapeutic Inc. - Company Cash Balance|TNXP (Tonix Pharma) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance